This brand name is authorized in New Zealand, South Africa
The drug PEXID contains one active pharmaceutical ingredient (API):
|
1
Perhexiline
UNII K7V8Y90G0H - PERHEXILINE MALEATE
|
|
Perhexiline maleate is an anti-anginal agent. Its mechanism of action as an anti-anginal agent has not been fully elucidated in humans; it is likely to have two consequences, increased myocardial efficiency, and decreased potential for impairment of myocardial function during ischaemia. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C08EX02 | Perhexiline | C Cardiovascular system → C08 Calcium channel blockers → C08E Non-selective calcium channel blockers → C08EX Other non-selective calcium channel blockers |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 1581 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): F/7.1.4/201 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
